Ships: 1-2 business days
Product Specific References for Applications and Species
Western Blot: Human | ||
PMID | Dilution | Publication |
28921811 | not listed | Zhao, X, et al. 2018. A role for the non-receptor tyrosine kinase ACK1 in TNF-alpha-mediated apoptosis and proliferation in human intestinal epithelial caco-2 cells. Cell biology international, 1097-1105. |
25671697 | not listed | Cullen, S., et al. 2015. Redox-regulated pathway of tyrosine phosphorylation underlies NF-κB induction by an atypical pathway independent of the 26S proteasome. Biomolecules, 95-112. |
17533369 | not listed | Sethi, G., et al. 2007. Epidermal growth factor (EGF) activates nuclear factor-kappaB through IkappaBalpha kinase-independent but EGF receptor-kinase dependent tyrosine 42 phosphorylation of IkappaBalpha. Oncogene, 7324-7332. |
Western Blot: Mouse | ||
PMID | Dilution | Publication |
29175419 | not listed | Zhang, Y, et al. 2018. Exogenous oxidants activate nuclear factor kappa B through Toll-like receptor 4 stimulation to maintain inflammatory phenotype in macrophage. Biochemical pharmacology, 104-118. |
19835847 | not listed | Cullen, S.J., et al. 2010. Proteasome inhibition up-regulates inflammatory gene transcription induced by an atypical pathway of NF-kappaB activation. Biochemical pharmacology, 706-714. |
18768868 | 1:1000 | Naidu, S., et al. 2008. An atypical NF-kappa B-regulated pathway mediates phorbol ester-dependent heme oxygenase-1 gene activation in monocytes. Journal of Immunology, 4113-4123. |
17426256 | not listed | Boosani, C.S., et al. 2007. Regulation of COX-2 mediated signaling by alpha3 type IV noncollagenous domain in tumor angiogenesis. Blood, 1168-1177. |
Western Blot: Rat | ||
PMID | Dilution | Publication |
19074556 | not listed | Wright, C.J., et al. 2009. Hyperoxia-induced NF-kappaB activation occurs via a maturationally sensitive atypical pathway. American Journal of Physiology. Lung Cellular and Molecular Physiology, L296-L306. |